First Trust Switzerland AlphaDEX Fund (FSZ)

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2012	6.2%	15.4%	7.9%	7.5%	6.7%	10.1%	5.8%	7.9%	8.2%	8.9%	5.6%	6.5%	5.8%	7.2%
2013		25.5%	8.8%	7.9%	6.8%	11.0%	5.7%	8.1%	8.4%	9.3%	5.5%	6.6%	5.8%	7.3%
2014			-5.6%	0.1%	1.2%	7.6%	2.1%	5.5%	6.2%	7.4%	3.5%	4.8%	4.2%	5.9%
2015				6.0%	4.8%	12.4%	4.1%	7.9%	8.3%	9.4%	4.7%	6.1%	5.2%	7.0%
2016					3.5%	15.7%	3.5%	8.3%	8.8%	9.9%	4.5%	6.1%	5.1%	7.1%
2017						29.3%	3.5%	10.0%	10.1%	11.3%	4.6%	6.4%	5.3%	7.6%
2018							-17.2%	1.4%	4.4%	7.2%	0.3%	3.0%	2.3%	5.1%
2019								24.1%	17.2%	16.8%	5.2%	7.6%	5.9%	8.7%
2020									10.6%	13.3%	-0.4%	3.9%	2.6%	6.4%
2021										16.0%	-5.5%	1.7%	0.7%	5.5%
2022											-23.1%	-4.8%	-4.0%	3.1%
2023												17.8%	7.3%	13.6%
2024													-2.3%	11.6%
2025														27.4%

Distributions

*by ETF Portfolio Weight Last updated: Oct 01, 2026

Profit Margin Distribution

< 0%

10%

1y 3y N/A N/A

0 - 5%

0%

1y 3y N/A N/A

5 - 10%

4%

1y 3y N/A N/A

10 - 15%

0%

1y 3y N/A N/A

15 - 20%

17%

1y 3y N/A N/A

20 - 30%

50%

1y 3y N/A N/A

30 - 40%

19%

1y 3y N/A N/A

> 40%

0%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

10%

1y 3y N/A N/A

0 - 10

0%

1y 3y N/A N/A

10 - 15

42%

1y 3y N/A N/A

15 - 20

24%

1y 3y N/A N/A

20 - 25

16%

1y 3y N/A N/A

25 - 35

4%

1y 3y N/A N/A

35 - 50

4%

1y 3y N/A N/A

> 50

0%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

0%

1y 3y N/A N/A

45 - 60%

0%

1y 3y N/A N/A

30 - 45%

0%

1y 3y N/A N/A

15 - 30%

0%

1y 3y N/A N/A

Fair (±15%)

0%

1y 3y N/A N/A

Overvalued

15 - 30%

0%

1y 3y N/A N/A

30 - 45%

0%

1y 3y N/A N/A

45 - 60%

0%

1y 3y N/A N/A

> 60%

0%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

10.2%

1y 3y N/A N/A

Small Cap

0.0%

1y 3y N/A N/A

Mid Cap

18.6%

1y 3y N/A N/A

Large Cap

55.4%

1y 3y N/A N/A

Mega Cap

15.8%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Oct 01, 2026

79.0% Top 5 Holdings

100.0% Top 10 Holdings

100.0% Top 50 Holdings

100.0% Top 100 Holdings

Top 5 Companies

UBS UBS Group AG

19.7%

ROP Roper Technologies Inc

18.5%

NVS Novartis AG

15.8%

CFR Cullen Frost Bankers Inc.

14.8%

BAER Bridger Aerospace Group Holdings Inc

10.2%

Latest News

27 days ago • benzinga.com

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics Inc. (NASDAQ:DYN) stock is trading lower on Tuesday in reaction to Novartis AG's (NYSE:NVS) data from the global Phase 3 HARBOR s...

27 days ago • 247wallst.com

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) h...

27 days ago • reuters.com

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis' treatment for a muscle-wasting disorder failed in a trial, fueling inves...

Average metrics of all companies in portfolio

Last updated: Oct 04, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$89.1B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	2.00%	2.02%
Beta Indicates the relationship between the price performance of a share and the market.	0.65	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	18.39	23.08
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-1.1	-
Profitable Companies	89%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	13.25	19.24
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	3.83	9.85
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	3.42	12.6

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	21.11	11.97
Enterprise Value to Revenue Enterprise value divided by revenue	5.47	13.3
Total Debt to Enterprise Value Total debt divided by enterprise value	0.36	0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	1.37	0.32
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	20.42%	21.62%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+13.0%	+55.1%
Return on Equity Equity divided by market cap.	11.69%	1.73%
Return on Assets Indicates a company's profitability in relation to its total assets.	4.17%	3.97%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	7.80%	3.60%